GlassScriptPhysician profile
Mihael J Puc
NPI 1003847724
$2,095.26
in general payments reported to CMS, 2019-2025
7 companies · $1,293 in 2025
The $1,293 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.63 · 2021: $17.89 · 2022: $239 · 2023: $306 · 2024: $217 · 2025: $1,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,815.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $1,170.00 | 2025 | Rapiblyk |
| Edwards Lifesciences Corporation | $612.89 | 2020-2025 | Sapien 3 Ultra Resilia, Hemosphere |
| Abiomed | $198.66 | 2022-2025 | Impella |
| Mindray Ds USA, INC. | $42.59 | 2025 | Te7 Max, Te X |
| Amgen INC. | $34.09 | 2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.14 | 2024 | Lifevest |
| Masimo Corporation | $17.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mihael Puc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.